Literature DB >> 3396464

[Hyperfibrinogenemia and pathological plasma viscosity. Pathogenetic factors in unstable angina pectoris?].

M Leschke1, H Blanke, M Stellwaag, W Motz, B E Strauer.   

Abstract

Plasma viscosity and erythrocyte aggregation, as the most important rheological factors in the microcirculation, and fibrinogen were measured in the blood of groups of patients in various stages of coronary-heart disease. Patients with unstable angina had viscosity and fibrinogen levels, even before any manifest infarction, that were higher than those of patients with stable angina. Plasma viscosity and hyperfibrinogenaemia (1.39 +/- 0.08 mPa.s in 48 patients and 394.4 +/- 82.7 mg/dl, respectively, in 33) were comparable to the values in patients with acute myocardial infarction (1.37 +/- 0.09 mPa.s [n = 45] and 390.2 +/- 126.9 mg/dl [n = 27], but significantly higher (P less than 0.02) than in those with stable angina (1.33 +/- 0.08 mPa.s [n = 78] and 295.3 +/- 68.6 mg/dl [n = 44], respectively). This abnormal viscosity in unstable angina plays a part in increasing myocardial ischaemia because oxygen delivery is already diminished and capillary flow slowed down. It thus contributes to progression of the angina and must be taken into account as an additional pathogenetic factor in the clinical instability.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396464     DOI: 10.1055/s-2008-1067789

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

Review 1.  [Rheological determinants of end-organ damage].

Authors:  M Leschke; W Klimek; F Jung
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

Review 2.  Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.

Authors:  F C Schoebel; T W Jax; Y Fischer; B E Strauer; M Leschke
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

3.  Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.

Authors:  F C Schoebel; F Gradaus; K Ivens; P Heering; T W Jax; B Grabensee; B E Strauer; M Leschke
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

Review 4.  [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy].

Authors:  M Leschke; F C Schoebel; T W Jax; C M Schannwell; R Marx; B E Strauer
Journal:  Herz       Date:  1997-10       Impact factor: 1.443

5.  Nocturnal myocardial ischemia and cardiac arrhythmia in patients with sleep apnea with and without coronary heart disease.

Authors:  U Koehler; H Dübler; T Glaremin; H Junkermann; C Lübbers; T Ploch; J H Peter; T Pomykaj; P von Wichert
Journal:  Klin Wochenschr       Date:  1991-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.